Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZIPRASIDONE HYDROCHLORIDE USP, with a corresponding US DMF Number 24955.
Remarkably, this DMF maintains an Active status since its submission on October 12, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 27, 2014, and payment made on May 13, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II